Background Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) were historically thought to be distinct entities, often managed in isolation …
THA Tvedt, AK Vo, Ø Bruserud, H Reikvam - Journal of Clinical Medicine, 2021 - mdpi.com
Cytokine release syndrome (CRS) is an acute systemic inflammatory syndrome characterized by fever and multiple organ dysfunction associated with (i) chimeric antigen …
Antigen-specific immunotherapies have immense potential to harness and fortify the inherent antitumor capacity of the immune system. Due to their unparalleled success in …
EM Behrens - Autoimmunity reviews, 2008 - Elsevier
Macrophage Activation Syndrome (MAS), alternatively referred to as secondary hemophagocytic lymphohistiocytosis (HLH), is a complication of many rheumatic diseases …
Background Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) is a serious and potentially life threatening histiocytic disorder in children and …
S Bami, A Vagrecha, D Soberman… - Pediatric blood & …, 2020 - Wiley Online Library
Background Hemophagocytic lymphohistiocytosis (HLH) can be familial or secondary, which is often triggered by infection or malignancy. HLH therapy includes dexamethasone and …